Identification of cancer associated TP53/PIK3CA mutations in two patients’ plasma matching with primary tumor tissue was carried out using Ion AmpliSeqTM panel in a series of 11 patients with STS (43). This evidence concerns the gene TP53 and telomere syndrome.